Identification of residues in the BST-2 TM domain important for antagonism by HIV-1 Vpu using a gain-of-function approach

Frontiers in Microbiology

Volumn 2, Issue FEB, 2011, Pages

  Yoshida, Takeshi ^a   Kao, Sandra ^a   Strebel, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

BST 2; HIV 1; Restriction factor; Tetherin; Vpu

Indexed keywords

EID: 80053966922     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00035     Document Type: Article

References (60)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Andrew, A., and Strebel, K. (2010). HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms. Mol. Aspects Med. 31, 407-417.
3. Andrew, A. J., Miyagi, E., Kao, S., and Strebel, K. (2009). The formation of cysteine-linked dimers of BST-2/ tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology 6, 80.
4. Arnaud, F., Black, S. G., Murphy, L., Griffiths, D. J., Neil, S. J., Spencer, T. E., and Palmarini, M. (2010). Interplay between ovine bone marrow stromal cell antigen 2/tetherin and endogenous retroviruses. J. Virol. 84, 4415-4425.
5. Bartee, E., McCormack, A., and Fruh, K. (2006). Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2, e107. doi:10.1371/journal. ppat.0020107
6. Bour, S., Boulerice, F., and Wainberg, M. A. (1991). Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J. Virol. 65, 6387-6396.
7. Bour, S., Perrin, C., and Strebel, K. (1999). Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. J. Biol. Chem. 274, 33800-33806.
8. Bour, S., Schubert, U., and Strebel, K. (1995). The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69, 1510-1520.
9. Buonocore, L., Turi, T. G., Crise, B., and Rose, J. K. (1994). Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204, 482-486.
10. Crise, B., Buonocore, L., and Rose, J. K. (1990). CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64, 5585-5593.
11. Douglas, J. L., Viswanathan, K., McCarroll, M. N., Gustin, J. K., Fruh, K., and Moses, A. V. (2009). Vpu directs the degradation of the HIV restriction factor BST-2/tetherin via a {beta}TrCPdependent mechanism. J. Virol. 83, 7931-7947.
12. Dube, M., Roy, B. B., Guiot-Guillain, P., Binette, J., Mercier, J., Chiasson, A., and Cohen, E. A. (2010). Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 6, e1000856. doi:10.1371/journal. ppat.1000856
13. Dube, M., Roy, B. B., Guiot-Guillain, P., Mercier, J., Binette, J., Leung, G., and Cohen, E. A. (2009). Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 83, 4574-4590.
14. Goffinet, C., Allespach, I., Homann, S., Tervo, H. M., Habermann, A., Rupp, D., Oberbremer, L., Kern, C., Tibroni, N., Welsch, S., Krijnse-Locker, J., Banting, G., Krausslich, H. G., Fackler, O. T., and Keppler, O. T. (2009). HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5, 285-297.
15. Goto, T., Kennel, S. J., Abe, M., Takishita, M., Kosaka, M., Solomon, A., and Saito, S. (1994). A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84, 1922-1930.
16. Gupta, R. K., Hue, S., Schaller, T., Verschoor, E., Pillay, D., and Towers, G. J. (2009). Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5, e1000443. doi:10.1371/ journal.ppat.1000443
17. Habermann, A., Krijnse-Locker, J., Oberwinkler, H., Eckhardt, M., Homann, S., Andrew, A., Strebel, K., and Krausslich, H. G. (2010). CD317/ tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J. Virol. 84, 4646-4658.
18. Hinz, A., Miguet, N., Natrajan, G., Usami, Y., Yamanaka, H., Renesto, P., Hartlieb, B., McCarthy, A. A., Simorre, J. P., Gottlinger, H., and Weissenhorn, W. (2010). Structural basis of HIV-1 tethering to membranes by the BST-2/ tetherin ectodomain. Cell Host Microbe 7, 314-323.
19. Hout, D. R., Gomez, M. L., Pacyniak, E., Gomez, L. M., Fegley, B., Mulcahy, E. R., Hill, M. S., Culley, N., Pinson, D. M., Nothnick, W., Powers, M. F., Wong, S. W., and Stephens, E. B. (2006). Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIV(KU1bMC33)) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques. Virology 344, 541-559.
20. Hout, D. R., Gomez, M. L., Pacyniak, E., Gomez, L. M., Inbody, S. H., Mulcahy, E. R., Culley, N., Pinson, D. M., Powers, M. F., Wong, S. W., and Stephens, E. B. (2005). Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIV(TM)) that is less pathogenic for pig-tailed macaques. Virology 339, 56-69.
21. Ishikawa, J., Kaisho, T., Tomizawa, H., Lee, B. O., Kobune, Y., Inazawa, J., Oritani, K., Itoh, M., Ochi, T., Ishihara, K., and Hirano, T. (1995). Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26, 527-534.
22. Iwabu, Y., Fujita, H., Kinomoto, M., Kaneko, K., Ishizaka, Y., Tanaka, Y., Sata, T., and Tokunaga, K. (2009). HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284, 35060-35072.
23. Jabbar, M. A., and Nayak, D. P. (1990). Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 64, 6297-6304.
24. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., Johnson, W. E., Westmoreland, S., and Evans, D. T. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/ BST2. PLoS Pathog. 5, e1000429. doi:10.1371/journal.ppat.1000429
25. Jouvenet, N., Neil, S. J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., McNatt, M., Hatziioannou, T., and Bieniasz, P. D. (2009). Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83, 1837-1844.
26. Kaletsky, R. L., Francica, J. R., Agrawal-Gamse, C., and Bates, P. (2009). Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 106, 2886-2891.
27. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A., and Orenstein, J. M. (1990). The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621-629.
28. Kobayashi, T., Ode, H., Yoshida, T., Sato, K., Gee, P., Yamamoto, S. P., Ebina, H., Strebel, K., Sato, H., and Koyanagi, Y. (2011). Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J. Virol. 85, 932-945.
29. Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G. (2003). Bst-2/HM1.24 is a raftassociated apical membrane protein with an unusual topology. Traffic 4, 694-709.
30. Magadan, J. G., Perez-Victoria, F. J., Sougrat, R., Ye, Y., Strebel, K., and Bonifacino, J. S. (2010). Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 6, e1000869. doi:10.1371/journal.ppat.1000869
31. Maldarelli, F., Chen, M. Y., Willey, R. L., and Strebel, K. (1993). Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67, 5056-5061.
32. Masuyama, N., Kuronita, T., Tanaka, R., Muto, T., Hirota, Y., Takigawa, A., Fujita, H., Aso, Y., Amano, J., and Tanaka, Y. (2009). HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with {alpha}-adaptin. J. Biol. Chem. 284, 15927-15941.
33. Mattiuzzo, G., Ivol, S., and Takeuchi, Y. (2010). Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J. Virol. 84, 2618-2622.
34. McNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., Neil, S. J., and Bieniasz, P. D. (2009). Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5, e1000300. doi:10.1371/journal.ppat.1000300
35. Mitchell, R. S., Katsura, C., Skasko, M. A., Fitzpatrick, K., Lau, D., Ruiz, A., Stephens, E. B., Margottin-Goguet, F., Benarous, R., and Guatelli, J. C. (2009). Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5, e1000450. doi:10.1371/journal.ppat.1000450
36. Miyagi, E., Andrew, A. J., Kao, S., and Strebel, K. (2009). Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U.S.A. 106, 2868-2873.
37. Neil, S. J., Eastman, S. W., Jouvenet, N., and Bieniasz, P. D. (2006). HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog. 2, e39. doi:10.1371/journal. ppat.0020039
38. Neil, S. J., Sandrin, V., Sundquist, W. I., and Bieniasz, P. D. (2007). An interferonalpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2, 193-203.
39. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
40. Nguyen, K. L., llano, M., Akari, H., Miyagi, E., Poeschla, E. M., Strebel, K., and Bour, S. (2004). Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 319, 163-175.
41. Ohtomo, T., Sugamata, Y., Ozaki, Y., Ono, K., Yoshimura, Y., Kawai, S., Koishihara, Y., Ozaki, S., Kosaka, M., Hirano, T., and Tsuchiya, M. (1999). Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem. Biophys. Res. Commun. 258, 583-591.
42. Paul, M., Mazumder, S., Raja, N., and Jabbar, M. A. (1998). Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J. Virol. 72, 1270-1279.
43. Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., and Bieniasz, P. D. (2009). Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499-511.
44. Raja, N. U., Vincent, M. J., and Jabbar, M. A. (1994). Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4. Virology 204, 357-366.
45. Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., and Banting, G. (2007). Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J. Cell Sci. 120, 3850-3858.
46. Rong, L., Zhang, J., Lu, J., Pan, Q., Lorgeoux, R. P., Aloysius, C., Guo, F., Liu, S. L., Wainberg, M. A., and Liang, C. (2009). The transmembrane domain of BST-2 determines its sensitivity to down-modulation by HIV-1 Vpu. J. Virol. 83, 7536-7546.
47. Sakai, H., Tokunaga, K., Kawamura, M., and Adachi, A. (1995). Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J. Gen. Virol. 76(Pt 11), 2717-2722.
48. Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., and Yasuda, J. (2009a). Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83, 2382-2385.
49. Sakuma, T., Sakurai, A., and Yasuda, J. (2009b). Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses. PLoS ONE 4, e6934. doi:10.1371/journal.pone.0006934
50. Schubert, U., Bour, S., Ferrer-Montiel, A. V., Montal, M., Maldarell, F., and Strebel, K. (1996). The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70, 809-819.
51. Strebel, K. (2007). HIV accessory genes Vif and Vpu. Adv. Pharmacol. 55, 199-232.
52. Strebel, K., Beck, E., Strohmaier, K., and Schaller, H. (1986). Characterization of foot and mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J. Virol. 57, 983-991.
53. Strebel, K., Klimkait, T., and Martin, M. A. (1988). A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241, 1221-1223.
54. Terwilliger, E. F., Cohen, E. A., Lu, Y. C., Sodroski, J. G., and Haseltine, W. A. (1989). Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. U.S.A. 86, 5163-5167.
55. Tiganos, E., Yao, X. J., Froborg, J., Daniel, N., and Cohen, E. A. (1997). Putative a-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J. Virol. 71, 4452-4460.
56. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., and Guatelli, J. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252.
57. Varthakavi, V., Smith, R. M., Bour, S. P., Strebel, K., and Spearman, P. (2003). Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc. Natl. Acad. Sci. U.S.A. 100, 15154-15159.
58. Varthakavi, V., Smith, R. M., Martin, K. L., Derdowski, A., Lapierre, L. A., Goldenring, J. R., and Spearman, P. (2006). The pericentriolar recycling endosome plays a key role in Vpumediated enhancement of HIV-1 particle release. Traffic 7, 298-307.
59. Willey, R. L., Buckler-White, A., and Strebel, K. (1994). Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. J. Virol. 68, 1207-1212.
60. Yao, X. J., Friborg, J., Checroune, F., Gratton, S., Boisvert, F., Sekaly, R. P., and Cohen, E. A. (1995). Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209, 615-623.